- Presentations
- 4
- Markets
- 1
Exxua is a brand of Gepirone marketed by Aytu Therapeutics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Gepirone
- Brand owner
- Aytu Therapeutics
- Registered in
- United States
- Strengths and forms
- 18.2 mg extended-release tablet, 36.3 mg extended-release tablet, 54.5 mg extended-release tablet, 72.6 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Exxua 18.2 mg extended-release tabletOral | Aytu Therapeutics | US FDA | Available on request |
| Exxua 36.3 mg extended-release tabletOral | Aytu Therapeutics | US FDA | Available on request |
| Exxua 54.5 mg extended-release tabletOral | Aytu Therapeutics | US FDA | Available on request |
| Exxua 72.6 mg extended-release tabletOral | Aytu Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Exxua
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.